Anja H. Gesierich

Josef Schneider Str. 2
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

Rapid regression of a mucosal melanoma after a single dose of immune checkpoint inhibitors.

Rapid regression of a mucosal melanoma after a single dose of immune checkpoint inhibitors.

Journal: European journal of dermatology : EJD

Published: May 25, 2026

Early Detection of Melanoma

Early Detection of Melanoma

Journal: MMW Fortschritte der Medizin

Published: May 12, 2026

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.

Journal: Future oncology (London, England)

Published: March 31, 2026

Supportive care for talquetamab-related dysgeusia in multiple myeloma: mixed-methods evidence, nutrition-focused flowchart, and digital companion concept.

Supportive care for talquetamab-related dysgeusia in multiple myeloma: mixed-methods evidence, nutrition-focused flowchart, and digital companion concept.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: February 20, 2026

Immune checkpoint inhibitor-induced bullous pemphigoid effectively controlled by dupilumab.

Immune checkpoint inhibitor-induced bullous pemphigoid effectively controlled by dupilumab.

Journal: European journal of dermatology : EJD

Published: January 29, 2026

Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG.

Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 16, 2026

Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study.

Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study.

Journal: Acta dermato-venereologica

Published: September 07, 2025

Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis.

Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis.

Journal: Journal for immunotherapy of cancer

Published: September 03, 2025

More than age: Impact of comorbidity and polypharmacy on immune-related adverse events, treatment discontinuation, and toxicity management in older patients receiving immune checkpoint inhibitors.

More than age: Impact of comorbidity and polypharmacy on immune-related adverse events, treatment discontinuation, and toxicity management in older patients receiving immune checkpoint inhibitors.

Journal: Journal of geriatric oncology

Published: July 07, 2025

Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma: results of a multicentre phase II trial.

Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma: results of a multicentre phase II trial.

Journal: The British journal of dermatology

Published: May 02, 2025

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial.

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial.

Journal: The British journal of dermatology

Published: April 08, 2025

Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers.

Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: February 24, 2025

Showing 1-12 of 94

Last Updated: 09/26/2026